With an established track record in providing expert support to direct cancer drug development projects from concept to clinic, the acquisition of PRECOS bolsters Crown Bioscience’s services global...
By combining their drug discovery and translational research platforms, Crown Bioscience and Horizon Discovery will help their customers select and advance the highest quality drug candidates to cl...
High-quality human disease models are crucial for generating ‘first-in-class’ patient-relevant targets and facilitating the development of novel oncology targets and early-stage drug discovery prog...
